Lemaitre Vascular [LMAT] vs Avantor [AVTR] Detailed Stock Comparison
Lemaitre Vascular
NASDAQ
Loading...
Avantor
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lemaitre Vascular wins in 11 metrics, Avantor wins in 8 metrics, with 0 ties. Lemaitre Vascular appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemaitre Vascular | Avantor | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 45.01 | 11.39 | Avantor |
| Price-to-Book Ratio | 5.76 | 1.25 | Avantor |
| Debt-to-Equity Ratio | 51.25 | 67.49 | Lemaitre Vascular |
| PEG Ratio | 42.53 | 10.18 | Avantor |
| EV/EBITDA | 30.14 | 10.91 | Avantor |
| Profit Margin (TTM) | 20.08% | 10.31% | Lemaitre Vascular |
| Operating Margin (TTM) | 25.13% | 7.63% | Lemaitre Vascular |
| EBITDA Margin (TTM) | 25.13% | 7.63% | Lemaitre Vascular |
| Return on Equity | 13.81% | 11.73% | Lemaitre Vascular |
| Return on Assets (TTM) | 7.28% | 3.24% | Lemaitre Vascular |
| Free Cash Flow (TTM) | $37.16M | $692.00M | Avantor |
| Dividend Yield | 0.98% | N/A | N/A |
| 1-Year Return | 10.17% | -53.96% | Lemaitre Vascular |
| Price-to-Sales Ratio (TTM) | 8.90 | 1.18 | Avantor |
| Enterprise Value | $1.96B | $11.63B | Avantor |
| EV/Revenue Ratio | 8.33 | 1.75 | Avantor |
| Gross Profit Margin (TTM) | 70.02% | 32.92% | Lemaitre Vascular |
| Revenue per Share (TTM) | $10 | $10 | Lemaitre Vascular |
| Earnings per Share (Diluted) | $2.05 | $1.01 | Lemaitre Vascular |
| Beta (Stock Volatility) | 0.79 | 0.96 | Lemaitre Vascular |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemaitre Vascular vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | -2.10% | 13.87% | 9.97% | 13.23% | -6.26% | 0.89% |
| Avantor | 1.05% | 1.23% | -16.36% | -6.35% | -39.51% | -45.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | 10.17% | 68.46% | 225.16% | 578.03% | 1,438.00% | 1,330.70% |
| Avantor | -53.96% | -59.73% | -44.39% | -20.69% | -20.69% | -20.69% |
Performance & Financial Health Analysis: Lemaitre Vascular vs Avantor
| Metric | LMAT | AVTR |
|---|---|---|
| Market Information | ||
| Market Cap | $2.09B | $7.84B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 186,980 | 19,228,950 |
| 90 Day Avg. Volume | 139,390 | 13,997,890 |
| Last Close | $92.28 | $11.50 |
| 52 Week Range | $71.42 - $109.58 | $10.82 - $27.83 |
| % from 52W High | -15.79% | -58.68% |
| All-Time High | $109.58 (Nov 25, 2024) | $44.37 (Sep 20, 2021) |
| % from All-Time High | -15.79% | -74.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.01% |
| Quarterly Earnings Growth | 0.17% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.10% |
| Operating Margin (TTM) | 0.25% | 0.08% |
| Return on Equity (TTM) | 0.14% | 0.12% |
| Debt to Equity (MRQ) | 51.25 | 67.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.02 | $9.22 |
| Cash per Share (MRQ) | $14.11 | $0.66 |
| Operating Cash Flow (TTM) | $58.76M | $681.80M |
| Levered Free Cash Flow (TTM) | $37.70M | $688.84M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.98% | N/A |
| Last 12-Month Dividend | $0.92 | N/A |
Valuation & Enterprise Metrics Analysis: Lemaitre Vascular vs Avantor
| Metric | LMAT | AVTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 45.01 | 11.39 |
| Forward P/E | 42.53 | 10.18 |
| PEG Ratio | 42.53 | 10.18 |
| Price to Sales (TTM) | 8.90 | 1.18 |
| Price to Book (MRQ) | 5.76 | 1.25 |
| Market Capitalization | ||
| Market Capitalization | $2.09B | $7.84B |
| Enterprise Value | $1.96B | $11.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.33 | 1.75 |
| Enterprise to EBITDA | 30.14 | 10.91 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 0.96 |
| Book Value per Share (MRQ) | $16.02 | $9.22 |
Financial Statements Comparison: Lemaitre Vascular vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMAT | AVTR |
|---|---|---|
| Revenue/Sales | $59.87M | $1.58B |
| Cost of Goods Sold | $18.45M | $1.05B |
| Gross Profit | $41.42M | $534.90M |
| Research & Development | $4.10M | N/A |
| Operating Income (EBIT) | $12.63M | $147.40M |
| EBITDA | $18.08M | $230.80M |
| Pre-Tax Income | $14.24M | $85.70M |
| Income Tax | $3.23M | $21.20M |
| Net Income (Profit) | $11.01M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMAT | AVTR |
|---|---|---|
| Cash & Equivalents | $25.34M | $315.70M |
| Total Current Assets | $408.11M | $2.28B |
| Total Current Liabilities | $24.75M | $2.03B |
| Long-Term Debt | $182.73M | $3.28B |
| Total Shareholders Equity | $347.57M | $6.10B |
| Retained Earnings | $151.58M | $2.27B |
| Property, Plant & Equipment | $41.34M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMAT | AVTR |
|---|---|---|
| Operating Cash Flow | $5.69M | $86.60M |
| Capital Expenditures | $-1.38M | N/A |
| Free Cash Flow | $7.66M | $81.30M |
| Debt Repayment | N/A | $-31.30M |
| Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
| Metric | LMAT | AVTR |
|---|---|---|
| Shares Short | 1.38M | 40.07M |
| Short Ratio | 9.42 | 3.41 |
| Short % of Float | 0.08% | 0.08% |
| Average Daily Volume (10 Day) | 186,980 | 19,228,950 |
| Average Daily Volume (90 Day) | 139,390 | 13,997,890 |
| Shares Outstanding | 22.55M | 680.80M |
| Float Shares | 20.69M | 664.21M |
| % Held by Insiders | 0.09% | 0.01% |
| % Held by Institutions | 0.95% | 1.00% |
Dividend Analysis & Yield Comparison: Lemaitre Vascular vs Avantor
| Metric | LMAT | AVTR |
|---|---|---|
| Last 12-Month Dividend | $0.92 | N/A |
| Last 12-Month Dividend Yield | 0.98% | N/A |
| 3-Year Avg Annual Dividend | $0.68 | N/A |
| 3-Year Avg Dividend Yield | 0.23% | N/A |
| 3-Year Total Dividends | $2.04 | N/A |
| Ex-Dividend Date | Aug 21, 2025 | N/A |